Intage Holdings Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Consolidated Earnings Guidance for the Six Months and Full Year of the Fiscal Year Ending March 31, 2017
August 04, 2016
Share
Intage Holdings Inc. reported consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net sales of JPY 9,857 million against JPY 9,327 million a year ago. Operating income was JPY 492 million against JPY 402 million a year ago. Ordinary income was JPY 481 million against JPY 418 million a year ago. Net income attributable to owners of parent was JPY 307 million against JPY 240 million a year ago. Net income per share was JPY 15.42 against JPY 12.06 a year ago. Profit before income taxes was JPY 6,865 million against JPY 3,944 million a year ago.
The company provided consolidated earnings guidance for the six months and full year of the fiscal year ending March 31, 2017. For the six months, the company expects net sales of JPY 22,000 million, operating income of JPY 1,400 million, ordinary income of JPY 1,350 million, net income attributable to owners of parent of JPY 850 million or JPY 42.58 per share.
For the full year, the company expects net sales of JPY 48,000 million, operating income of JPY 4,200 million, ordinary income of JPY 4,250 million, net income attributable to owners of parent of JPY 2,650 million or JPY 132.75 per share.
INTAGE HOLDINGS Inc., formerly INTAGE Inc., is a provider of marketing research and consulting services. The Market Research and Consulting segment is engaged in marketing research operations, including customer panel research, retail shop panel research and other research activities; customized research services, including Internet research, mail survey, visiting interview survey and qualitative research, as well as the provision of related consulting services. The System Solution segment is engaged in the development and sale of software, the operation of systems and data centers, and the provision of various related consulting services. The Drug Development Support segment is engaged in the contract research organization (CRO) business. As of March 31, 2014, the Company had 24 subsidiaries and one associated company.
Intage Holdings Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Consolidated Earnings Guidance for the Six Months and Full Year of the Fiscal Year Ending March 31, 2017